Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment

Cancer and Metastasis Reviews

Volumn 27, Issue 1, 2008, Pages 67-73

  Taylor, Jennifer ^a   Hickson, Jonathan ^a,c   Lotan, Tamara ^a   Yamada, Diane Seiko ^a   Rinker Schaeffer, Carrie ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

Dormancy; Metastasis; Metastasis suppressor; MKK4 JNKK1; SAPK

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; STRESS ACTIVATED PROTEIN KINASE 1;

CANCER CELL; CANCER GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE FREE SURVIVAL; EPIGENETICS; GENE MUTATION; METASTASIS; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SUPPRESSOR GENE;

ANIMALS; HUMANS; MAP KINASE KINASE 4; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 38549126080     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9106-7     Document Type: Review

References (40)

1. Steeg, P. S. (2006). Tumor metastasis: Mechanistic insights and clinical challenges. Nature Medicine, 12, 895-904.
2. Ward, J. F., & Moul, J. W. (2005). Rising prostate-specific antigen after primary prostate cancer therapy. Nature Clinical Practice. Urology, 2, 174-182.
3. Steeg, P. (2003). Metastasis suppressors alter the signal transduction of cancer cells. Nature Reviews. Cancer, 3, 55-63.
4. Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563-572.
5. Kauffman, E. C., Robinson, V. L., Stadler, W. M., Sokoloff, M. H., & Rinker-Schaeffer, C. W. (2003). Metastasis suppression: The evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. Journal of Urology, 169, 1122-1133.
6. Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., et al. (1998). Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. American Journal of Pathology, 153, 865-873.
7. Nakao, A., Fujii, T., Sugimoto, H., Kanazumi, N., Nomoto, S., Kodera, Y., et al. (2006). Oncological problems in pancreatic cancer surgery. World Journal of Gastroenterology, 12, 4466-4472.
8. Rinker-Schaeffer, C. W., O'Keefe, J. P., Welch, D. R., & Theodorescu, D. (2006). Metastasis suppressor proteins: Discovery, molecular mechanisms, and clinical application. Clinical Cancer Research, 12, 3882-3889.
9. Yang, D., Tournier, C., Wysk, M., Lu, H. T., Xu, J., Davis, R. J., et al. (1997). Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America, 94, 3004-3009.
10. Ganiatsas, S., Kwee, L., Fujiwara, Y., Perkins, A., Ikeda, T., & Labow, M. A. (1998). SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proceedings of the National Academy of Sciences of the United States of America, 95, 6881-6886.
11. Vander Griend, D. J., Kocherginsky, M., Hickson, J. A., Stadler, W. M., Lin, A., & Rinker-Schaeffer, C. W. (2005). Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Research, 65, 10984-10991.
12. Hickson, J. A., Huo, D., Vander Griend, D. J., Lin, A., Rinker-Schaeffer, C. W., & Yamada, S. D. (2006). The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Research, 66, 2264-2270.
13. Kyriakis, J. M., & Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews, 81, 807-869.
14. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., et al. (2001). Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrine Reviews, 22, 153-183.
15. Ip, Y. T., & Davis, R. J. (1998). Signal transduction by the c-Jun N-terminal kinase (JNK)-From inflammation to development. Current Opinion in Cell Biology, 10, 205-219.
16. Lin, A. (2003). Activation of the JNK signaling pathway: Breaking the brake on apoptosis. Bioessays, 25, 17-24.
17. Yoshida, B. A., Dubauskas, Z., Chekmareva, M. A., Christiano, T. R., Stadler, W. M., & Rinker-Schaeffer, C. W. (1999). Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Research, 59, 5483-5487.
18. Yamada, S. D., Hickson, J. A., Hrobowski, Y., Vander Griend, D. J., Benson, D., Montag, A., et al. (2002). Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Research, 62, 6717-6723.
19. Davis, R. J. (1999). Signal transduction by the c-Jun N-terminal kinase. Biochemical Society Symposium, 64, 1-12.
20. Karin, M., Liu, Z., & Zandi, E. (1997). AP-1 function and regulation. Current Opinion in Cell Biology, 9, 240-246.
21. van Dam, H., & Castellazzi, M. (2001). Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene, 20, 2453-2464.
22. Shaulian, E., & Karin, M. (2001). AP-1 in cell proliferation and survival. Oncogene, 20, 2390-2400.
23. Hayakawa, J., Mittal, S., Wang, Y., Korkmaz, K. S., Adamson, E., English, C., et al. (2004). Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Molecular Cell, 16, 521-535.
24. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R., & Pouyssegur, J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. Journal of Biological Chemistry, 271, 20608-20616.
25. Shaulian, E., & Karin, M. (2002). AP-1 as a regulator of cell life and death. Natural Cell Biology, 4, E131-136.
26. Vogt, P. K. (2001). Jun, the oncoprotein. Oncogene, 20, 2365-2377.
27. Rinehart-Kim, J., Johnston, M., Birrer, M., & Bos, T. (2000). Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun. International Journal of Cancer, 88, 180-190.
28. Kennedy, N. J., & Davis, R. J. (2003). Role of JNK in tumor development. Cell Cycle, 2, 199-201.
29. Shim, J., Lee, H., Park, J., Kim, H., & Choi, E. J. (1996). A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature, 381, 804-806.
30. MacCorkle, R. A., & Tan, T. H. (2005). Mitogen-activated protein kinases in cell-cycle control. Cell Biochemistry and Biophysics, 43, 451-461.
31. Mikhailov, A., Shinohara, M., & Rieder, C. L. (2005). The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle, 4, 57-62.
32. Takenaka, K., Moriguchi, T., & Nishida, E. (1998). Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science, 280, 599-602.
33. Reinhardt, H. C., Aslanian, A. S., Lees, J. A., & Yaffe, M. B. (2007). p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell, 11, 175-189.
34. Paget, S. (1889). The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Reviews, 8, 98-101.
35. Paget, S. (1989). The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Reviews, 8, 98-101.
36. Miller-Jensen, K., Janes, K. A., Brugge, J. S., & Lauffenburger, D. A. (2007). Common effector processing mediates cell-specific responses to stimuli. Nature, 448, 604-608.
37. Guo, W., & Giancotti, F. G. (2004). Integrin signalling during tumour progression. Nature Reviews. Molecular Cell Biology, 5, 816-826.
38. Ossowski, L., & Aguirre-Ghiso, J. A. (2000). Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth. Current Opinion in Cell Biology, 12, 613-620.
39. Zavadil, J., & Bottinger, E. P. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764-5774.
40. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA Cancer Journal for Clinician, 55, 10-30.